All the Active Ingredient Drugs
Estrogen, Progestogen. Drospirenone 3 mg, Ethynilestradiol 0.03 mg. TABS: 1 x 21, 3 x 21. 1 tab. dly at the
same time for 21 days foll. by 7 days tab
free. See lit.
C/I: Current or hist. of VTE or pulm. embol. ,
Known hereditary or acquired predispose.
for VTE such as APC resistance, (includ.
Factor V Leiden), antithrombin-III-defic.,
protein C defic., protein S defic., major
surgery with prolon. immobilization., A
high risk of VTE due to the of multiple risk
factors, current or history of ATE(e.g. MI) or
prodromal condition (e.g. angina pectoris),
current stroke, history of stroke or
prodromal condition (e.g. TIA, Known
hereditary or acquir. predispose. for ATE,
such as hyperhomocysteinaemia and
anticoag.), History of migraine with focal neurology. sympt, A high risk of ATE due to
multiple risk factors or to the presence of
one serious risk factor such as: diabetes
mell.with vasc.sympt., Severe HTN, Severe
dyslipoproteinaemia, Presence/ hist. of
severe hepatic dis., Severe renal insuff. or
acute ren. fail Presence or hist. of liver
tumours (benign or malig.), Known or
suspected sex-steroid influenced
malignancies (e.g. of the genital organs or
the breasts), Undiagnosed vag. bleed.